Cipla Ltd. Hits 52-Week High, Outperforms Sensex in Pharma Industry
Cipla Ltd., a leading pharmaceutical company in India, reached a 52-week high of Rs. 1341.25 on January 11, 2024. The stock has shown a consecutive gain of 4.95% in the last 3 days and is currently trading above its moving averages. Cipla has outperformed the Sensex, showcasing its strong growth and stability in the pharma industry.
Cipla Ltd., a leading pharmaceutical company in India, has recently hit a 52-week high on January 11, 2024. This positive news has been welcomed by investors and market experts, with MarketsMOJO giving a 'Buy' call for the stock.
The stock price of Cipla Ltd. reached a new high of Rs. 1341.25, showing a strong performance in line with the sector. This marks a consecutive gain for the company, with the stock rising 4.95% in the last 3 days. The stock has also traded in a narrow range of Rs. 11.3, indicating stability in its performance.
Cipla Ltd. has also shown high volatility today, with an intraday volatility of 170.05%. However, this has not affected its overall performance, as the stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In comparison to the Sensex, Cipla Ltd. has outperformed with a 1-year performance of 27.40%, while the Sensex has shown a performance of 19.63%. This showcases the strong growth and stability of the company in the pharma industry.
Cipla Ltd. is a largecap company in the pharma industry, known for its quality products and strong market presence. With its recent 52-week high, the company continues to show promising growth and potential for investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
